Human Genome Epidemiology Literature Finder
|
Records 1 - 15 (of 15 Records) |
| Query Trace: Leukemia and CDA[original query] |
|---|
| Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia. Blood 2006 Jun 107 (12): 4871-9. Monzo Mariano, Brunet Salut, Urbano-Ispizua Alvaro, Navarro Alfons, Perea Granada, Esteve Jordi, Artells Rosa, Granell Miquel, Berlanga Juan, Ribera Josep M, Bueno Javier, Llorente Andreu, Guardia Ramon, Tormo Mar, Torres Pio, Nomdedéu Josep F, Montserrat Emili, Sierra Jordi, |
| [Study on the relationship between human cytidine deaminase gene polymorphisms and Ara-C sensitivity]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2008 Jul 29 (7): 459-63. Chen Xiao-wen, Yue Li-jie, Li Cheng-rong, Li Chang-gang, Shi Hong-song, Zhang M |
| Effect of genetic alterations of cytarabine- metabolizing enzymes in childhood acute lymphoblastic leukemia. Hematology/oncology and stem cell therapy 2010 3 (3): 103-8. Banklau Chumphorn, Jindadamrongwech Sumalee, Sawangpanich Ruchchadol, Apibal Suntaree, Hongeng Suradej, Paisooksantivatana Karan, Pakakasama Sama |
| Association of polymorphisms of cytosine arabinoside-metabolizing enzyme gene with therapeutic efficacy for acute myeloid leukemia. Chinese medical journal 2012 Jun 125 (12): 2137-43. Xu Pei-Pei, Chen Bao-An, Feng Ji-Feng, Cheng Lu, Xia Guo-Hua, Li Yu-Feng, Qian Jun, Ding Jia-Hua, Lu Zu-Hong, Wang Xue-Mei, Xu Ke, Schultz Margar |
| Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5'-nucleotidase. American journal of hematology 2013 Dec 88 (12): 1001-6. Falk Ingrid Jakobsen, Fyrberg Anna, Paul Esbjörn, Nahi Hareth, Hermanson Monica, Rosenquist Richard, Höglund Martin, Palmqvist Lars, Stockelberg Dick, Wei Yuan, Gréen Henrik, Lotfi Kouro |
| SLC29A1 single nucleotide polymorphisms as independent prognostic predictors for survival of patients with acute myeloid leukemia: an in vitro study. Journal of experimental & clinical cancer research : CR 2014 33 90. Wan Haixia, Zhu Jianyi, Chen Fangyuan, Xiao Fei, Huang Honghui, Han Xiaofeng, Zhong Lu, Zhong Hua, Xu Lan, Ni Beiwen, Zhong Jih |
| Cytidine deaminase polymorphisms and worse treatment response in normal karyotype AML. Journal of human genetics 2015 Sep . Hyo Kim Lyoung, Sub Cheong Hyun, Koh Youngil, Ahn Kwang-Sung, Lee Chansu, Kim Hyung-Lae, Doo Shin Hyoung, Yoon Sung-S |
| Role of Genetic Polymorphisms of Deoxycytidine Kinase and Cytidine Deaminase to Predict Risk of Death in Children with Acute Myeloid Leukemia. BioMed research international 2015 2015 309491. Medina-Sanson Aurora, Ramírez-Pacheco Arturo, Moreno-Guerrero Silvia Selene, Dorantes-Acosta Elisa María, Sánchez-Preza Metzeri, Reyes-López Alfon |
| Impact of single nucleotide polymorphisms of cytarabine metabolic genes on drug toxicity in childhood acute lymphoblastic leukemia. Pediatric blood & cancer 2015 Apr 62 (4): 622-8. Gabor Krisztina Mita, Schermann Geza, Lautner-Csorba Orsolya, Rarosi Ferenc, Erdelyi Daniel J, Endreffy Emoke, Berek Krisztina, Bartyik Katalin, Bereczki Csaba, Szalai Csaba, Semsei Agnes |
| Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment. Leukemia & lymphoma 2017 12 58 (12): 2880-2894. Megías-Vericat Juan Eduardo, Montesinos Pau, Herrero María José, Moscardó Federico, Bosó Virginia, Martínez-Cuadrón David, Rojas Luis, Rodríguez-Veiga Rebeca, Boluda Blanca, Sendra Luis, Cervera José, Poveda José Luis, Sanz Miguel Ángel, Aliño Salvador |
| sIL2R ratio as early marker for response in hairy cell leukemia and the prognostic relevance of IL28B genotype to interferon-a therapy. Annals of hematology 2017 Feb . Jud Stéphanie, Goede Jeroen S, Senn Oliver, Spanaus Katharina, Manz Markus G, Benz Rudo |
| CDA as a predictive marker for life-threatening toxicities in patients with AML treated with cytarabine. Blood advances 2018 Mar 2 (5): 462-469. Fanciullino Raphaelle, Farnault Laure, Donnette Mélanie, Imbs Diane-Charlotte, Roche Catherine, Venton Geoffroy, Berda-Haddad Yael, Ivanov Vadim, Ciccolini Joseph, Ouafik L'Houcine, Lacarelle Bruno, Costello Reg |
| 5'-nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate-risk cytogenetics. European journal of haematology 2022 Sep . Díaz-Santa Johana, Rodríguez-Romanos Rocío, Coll Rosa, Osca Gemma, Pratcorona Marta, González-Bártulos Marta, Garrido Ana, Angona Anna, Talarn Carme, Tormo Mar, Arnan Montserrat, Vives Susanna, Salamero Olga, Tuset Esperanza, Lloveras Natàlia, Díez Isabel, Zamora Lurdes, Bargay Joan, Sampol Antonia, Cruz David, Vila Jordi, Sitges Marta, Garcia Antoni, Vall-Llovera Ferran, Esteve Jordi, Sierra Jorge, Gallardo David, |
| Differences in actionable genomic alterations between brain metastases and non?brain metastases in patients with non?small cell lung cancer. International journal of oncology 2022 Sep 61 (3): . Nian Rui, Jiang Huihui, Zhao Jiangman, Hou Wanle, Zhang Hua, Ma Jiangtao, Lv Pengbiao, Jiang Lisha, Wang Yongpan, Xu Yue, Wu Shouxin, Lou Jingwei, Li Wanj |
| Pharmacogenetics of ABCB1, CDA, DCK, GSTT1, GSTM1 and outcomes in a cohort of pediatric acute myeloid leukemia patients from Colombia. Cancer reports (Hoboken, N.J.) 2022 11 e1744. Yunis Luz K, Linares-Ballesteros Adriana, Aponte Nelson, Barros Gisela, García Johnny, Niño Laura, Uribe Gloria, Quintero Edna, Yunis Juan |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 11, 2023
- Content source: